Production Introduction: Pefloxacin is a quinolone antibacterial drug that blocks DNA replication by inhibiting DNA gyrase. It can treat various infections caused by pefloxacin-sensitive bacteria: urinary tract infections; respiratory tract infections; ear, nose, and throat infections; gynecological and reproductive system infections; abdominal and liver and biliary system infections; bone and joint infections; skin Infection; sepsis and endocarditis; meningitis.
Application:
Antibiotic drugs for the treatment of Escherichia coli, dysentery bacillus, influenzae, Staphylococcus aureus and other infections;
The third generation of quinolones has a broad spectrum of antimicrobial activity, and its antimicrobial spectrum and activity are similar to norfloxacin. Inhibits or kills bacteria by interfering with DNA replication and the synthesis of bacterial proteins. It has a strong antibacterial effect on staphylococcus aureus, a variety of gram-negative bacteria and strains resistant to ampicillin and TMP cephalosporin V. It is as effective on intestinal bacteria and the third generation cephalosporin, but has a poor effect on anaerobic bacteria, Mycobacterium tuberculosis and Clostridium. Resistance is less likely to develop. Used for sepsis, bacterial meningitis, respiratory tract, urethra, kidney, liver, gynaecological diseases, bone and joint infections.